Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese Population

Trial Identifier: D9612R00010
Sponsor:AstraZeneca
NCTID:NCT03118778
Start Date:April 2017
Primary Completion Date: July 2017
Study Completion Date: July 2017
Condition: Digestive & Intestinal - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

CountryLocation
China Beijing, China, 100013